Loading...
The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
Breast cancer tumors that demonstrate gene amplification or overexpression of human epidermal growth factor receptor 2 (HER2) are classified as HER2-positive. They account for approximately 15% of all breast cancers and represent an adverse prognostic factor. Over the past years, many new therapies...
Na minha lista:
| Udgivet i: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445592/ https://ncbi.nlm.nih.gov/pubmed/26056489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S61579 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|